TY - JOUR TI - MDM2 induces EMT via the B‑Raf signaling pathway through 14‑3‑3 AU - Ou, Mengting AU - Xu, Xichao AU - Chen, Ying AU - Li, Li AU - Zhang, Lu AU - Liao, Yi AU - Sun, Weichao AU - Quach, Christine AU - Feng, Jianguo AU - Tang, Liling T2 - Oncology Reports AB - MDM2 proto‑oncogene, E3 ubiquitin protein ligase (MDM2) is a well‑known oncogene and has been reported to be closely associated with epithelial‑to‑mesenchymal transition (EMT). The present study first demonstrated that the expression levels of MDM2 were markedly increased in TGF‑β‑induced EMT using quantitative PCR and western blotting. In addition, MDM2 was demonstrated to be associated with pathological grade in clinical glioma samples by immunohistochemical staining. Furthermore, overexpression of MDM2 promoted EMT in glioma, lung cancer and breast cancer cell lines using a scratch wound migration assay. Subsequently, the present study explored the mechanism by which MDM2 promoted EMT and revealed that MDM2 induced EMT by upregulating EMT‑related transcription factors via activation of the B‑Raf signaling pathway through tyrosine 3‑monooxygenase activation protein ε using RNA sequencing and western blotting. This mechanism depended on the p53 gene. Furthermore, in vivo experiments and the colony formation experiment demonstrated that MDM2 could promote tumor progression and induce EMT via the B‑Raf signaling pathway. Since EMT contributes to increased drug resistance in tumor cells, the present study also explored the relationship between MDM2 and drug sensitivity using an MTT assay, and identified that MDM2 promoted cell insensitivity to silibinin treatment in an EMT‑dependent manner. This finding is crucial for the development of cancer therapies and can also provide novel research avenues for future biological and clinical studies. DA - 2021/07/01/ PY - 2021 DO - 10.3892/or.2021.8071 DP - www.spandidos-publications.com VL - 46 IS - 1 SP - 1 EP - 19 SN - 1021-335X UR - https://www.spandidos-publications.com/10.3892/or.2021.8071 Y2 - 2021/05/12/21:44:17 ER -